Table 2. Primary histopathology and laboratory findings for HIV-infected patients.
| Granulomatous disease / TB | Cholangiopathy | Steatosis | Malignancy* | Fibrosis/cirrhosis | p | |
|---|---|---|---|---|---|---|
| Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | Median (IQR) | ||
| n (%) | 28 (26) | 11 (10) | 23 (21) | 11 (10) | 7 (6) | |
| CD4 count (cells/mm3) | 135 (69, 226) | 105 (60, 494) | 176 (91, 253) | 225 (89, 362) | 365 (306, 513) | 0.5 |
| ALT (U/L) | 57 (45, 112) | 31 (20, 63) | 50 (41, 76) | 194 | 63 (43, 113) | 0.5 |
| AST (U/L) | 105 (72, 260) | 47 (10, 59) | 112 (101, 122) | 271 | 98 (52, 155) | 0.4 |
| Alkaline phosphatase (U/L) | 382 (219, 713) | 462 (328, 1757) | 275 (260, 359) | 1913 | 200 (187, 307) | 0.03 |
| Total bilirubin (μmol/L) | 28 (13, 40) | 11 (5, 20) | 18 (12, 33) | 96 | 24 (19,105) | 0.5 |
*Patients with malignancy lacked most laboratory data